Cargando…

TAS2940, a novel brain‐penetrable pan‐ERBB inhibitor, for tumors with HER2 and EGFR aberrations

Genetic alterations in human epidermal growth factor receptor type 2 (HER2)/epidermal growth factor receptor (EGFR) are commonly associated with breast and lung cancers and glioblastomas. Cancers with avian erythroblastosis oncogene B (ERBB) deregulation are highly metastatic and can cause primary b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oguchi, Kei, Araki, Hikari, Tsuji, Shingo, Nakamura, Masayuki, Miura, Akihiro, Funabashi, Kaoru, Osada, Akiko, Tanaka, Sakiho, Suzuki, Takamasa, Kobayashi, Susumu S., Mizuarai, Shinji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899605/ https://www.ncbi.nlm.nih.gov/pubmed/36282234 http://dx.doi.org/10.1111/cas.15617

Ejemplares similares

A semimechanistic population pharmacokinetic and pharmacodynamic model incorporating autoinduction for the dose justification of TAS‐114
por: Araki, Hikari, et al.
Publicado: (2021)

THER-01. PRECLINICAL DEVELOPMENT OF EO1001, A NOVEL IRREVERSIBLE BRAIN PENETRATING PAN-ErbB INHIBITOR
por: Shen, Wang, et al.
Publicado: (2019)

Novel Management of Rhinophyma by Patterned Ablative 2940nm Erbium:YAG Laser
por: Badawi, Ashraf, et al.
Publicado: (2020)

The use of the Er:YAG 2940nm laser associated with amorolfine lacquer in the treatment of onychomycosis()
por: de Morais, Orlando Oliveira, et al.
Publicado: (2013)

Comparative Study of Transmission of 2940 nm Wavelength in Six Different Aesthetic Orthodontic Brackets
por: Zamzam, Mohammad Khare, et al.
Publicado: (2023)

Efficacy and safety of long pulse 1064 and 2940 nm lasers in noninvasive lipolysis and skin tightening
por: Vas, Krisztina, et al.
Publicado: (2019)

Penetrating particle ANalyzer (PAN)
por: Wu, X., et al.
Publicado: (2019)

Repeated oral dosing of TAS-102 confers high trifluridine incorporation into DNA and sustained antitumor activity in mouse models
por: TANAKA, NOZOMU, et al.
Publicado: (2014)

Shieldings: TAS
Publicado: (2004)

Shieldings: TAS
Publicado: (2004)

Lichen Amyloidosis: Novel Treatment with Fractional Ablative 2,940 nm Erbium: YAG Laser Treatment
por: Anitha, B, et al.
Publicado: (2012)

70. A PHASE 1–2 CLINICAL TRIAL OF EO1001, A NOVEL IRREVERSIBLE pan-ErbB INHIBITOR WITH PROMISING BRAIN PENETRATION
por: Wheeler, Helen, et al.
Publicado: (2020)

Aberrant methylation of ERBB pathway genes in sporadic colorectal cancer
por: Szmida, Elzbieta, et al.
Publicado: (2014)

Successful use of a fractional 2940-nm laser in treating chronic, severe erosive pustular dermatosis of the scalp
por: Grubbs, Hailey E., et al.
Publicado: (2019)

Periocular rejuvenation using a unique non-ablative long-pulse 2940 nm Er:YAG laser
por: Badawi, Ashraf, et al.
Publicado: (2021)

TAS1553, a small molecule subunit interaction inhibitor of ribonucleotide reductase, exhibits antitumor activity by causing DNA replication stress
por: Ueno, Hiroyuki, et al.
Publicado: (2022)

Effect of Topical 5-Fluorouracil Alone versus Its Combination with Erbium:YAG (2940 nm) Laser in Treatment of Vitiligo
por: Abdelwahab, Mahetab, et al.
Publicado: (2020)

2940. Weaving Federal and Private Funding to Achieve Hepatitis C Elimination Goals at Syringe Services Programs in Rural Kentucky
por: Van Sickels, Nicholas, et al.
Publicado: (2023)

Vanillin Activates Human Bitter Taste Receptors TAS2R14, TAS2R20, and TAS2R39
por: Morini, Gabriella, et al.
Publicado: (2021)

Modulation of tumor immune microenvironment by TAS-115, a multi-receptor tyrosine kinase inhibitor, promotes antitumor immunity and contributes anti-PD-1 antibody therapy
por: Shibutani, Toshihiro, et al.
Publicado: (2023)

Eco-Geographical Diversification of Bitter Taste Receptor Genes (TAS2Rs) among Subspecies of Chimpanzees (Pan troglodytes)
por: Hayakawa, Takashi, et al.
Publicado: (2012)

TRLS-06. A Phase 1–2 clinical trial of EO1001 (APL-122), a novel irreversible pan-ErbB inhibitor with promising brain penetration
por: Frentzas, Sophia, et al.
Publicado: (2021)

Tas chebal : jun chajp a'tel pajbil /
por: González Dillon, Mónica
Publicado: (2013)

LOXL2 induces aberrant acinar morphogenesis via ErbB2 signaling
por: Chang, Joan, et al.
Publicado: (2013)

Fractional erbium-doped yttrium aluminum garnet laser 2940 nm-assisted delivery of topical timolol solution for the treatment of histiocytoid hemangioma
por: Albeshri, Mohammed, et al.
Publicado: (2021)

Gingival Depigmentation Using Diode 980 nm and Erbium-YAG 2940 nm Lasers: A Split-Mouth Clinical Comparative Study
por: Jnaid Harb, Zaid Kamel, et al.
Publicado: (2021)

Second-Line Treatment of NSCLC—The Pan-ErbB Inhibitor Afatinib in Times of Shifting Paradigms
por: Köhler, Jens
Publicado: (2017)

A Pre-Clinical Assessment of the Pan-ERBB Inhibitor Dacomitinib in Pediatric and Adult Brain Tumors
por: Endersby, Raelene, et al.
Publicado: (2018)

Breaking bad family ties: Pan-ERBB blockers inhibit KRAS driven lung tumorigenesis
por: Moll, Herwig P., et al.
Publicado: (2018)

Dual Inhibition of KRAS(G12D) and Pan-ERBB Is Synergistic in Pancreatic Ductal Adenocarcinoma
por: Gulay, Kevin Christian Montecillo, et al.
Publicado: (2023)

Energy Deposition in the Triplet and TAS Issues
por: Broggi, F
Publicado: (2008)

Implementation of TasP: challenges and opportunities
por: Lange, Joep
Publicado: (2014)

TAS-102 and the quest for predictive biomarkers
por: van der Velden, Daphne L, et al.
Publicado: (2017)

Cost-effectiveness of TAS-102 plus bevacizumab versus TAS-102 monotherapy in patients with metastatic colorectal cancer
por: Sugiura, Kiyoaki, et al.
Publicado: (2021)

The Efficacy and Safety of Ablative Fractional Resurfacing Using a 2,940-Nm Er:YAG Laser for Traumatic Scars in the Early Posttraumatic Period
por: Kim, Sun Goo, et al.
Publicado: (2012)

Comparison of 2940 nm Er: YAG laser treatment in the microlaser peel, fractional ablative laser, or combined modes for the treatment of concave acne scars
por: Chen, Lei, et al.
Publicado: (2021)

Long-term efficacy of afatinib in a patient with squamous cell carcinoma of the lung and multiple ERBB family aberrations: afatinib in ERBB+ lung squamous cell carcinoma
por: Jian, Hong, et al.
Publicado: (2019)

Expression and Characterization of Kinase‐active v‐erbB Protein Using a Baculovirus Vector System
por: Morishita, Kaoru, et al.
Publicado: (1992)

Aberrant Corneal Homeostasis in Neurosurgery-Induced Neurotrophic Keratopathy
por: Oba, Shimpei, et al.
Publicado: (2022)

Tunable Contact Types and Interfacial Electronic Properties in TaS(2)/MoS(2) and TaS(2)/WSe(2) Heterostructures
por: Zhu, Xiangjiu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m8af0egmtjqb5henfuqcfk6nv4